| Mar 3, 2026 |
Mar 5, 2026 |
Murtagh Nigel J
|
Chief Risk Officer |
Sell |
20.0
|
-7,203
|
-10.65%
|
✗
|
$681.5K |
| Mar 3, 2026 |
Mar 5, 2026 |
Craig Jonathan M.
|
MD, Head of Investor Services |
Sell |
17.5
|
-14,481
|
-100.00%
|
✗
|
$1.4M |
| Mar 3, 2026 |
Mar 5, 2026 |
Howard Dennis
|
MD, Chief Tech, OPS & Data Off |
Sell |
20.0
|
-10,108
|
-49.12%
|
✗
|
$956.2K |
| Mar 2, 2026 |
Mar 4, 2026 |
Beatty Jonathan S
|
MD, Head of Advisor Services |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 2, 2026 |
Mar 4, 2026 |
Verdeschi Michael D
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2026 |
Mar 3, 2026 |
Woolway Paul V
|
MD, Chief Banking Officer |
Sell |
37.5
|
-15,884
|
-6.55%
|
✗
|
$2.3M |
| Mar 1, 2026 |
Mar 3, 2026 |
Craig Jonathan M.
|
MD, Head of Investor Services |
Sell |
100.0
|
+14,481
|
100.00%
|
✗
|
$1.1M |
| Mar 1, 2026 |
Mar 3, 2026 |
Murtagh Nigel J
|
Chief Risk Officer |
Sell |
92.5
|
+7,203
|
5.35%
|
✗
|
$868.1K |
| Mar 1, 2026 |
Mar 3, 2026 |
Howard Dennis
|
MD, Chief Tech, OPS & Data Off |
Sell |
97.5
|
+10,108
|
96.54%
|
✗
|
$591.3K |
| Mar 1, 2026 |
Mar 3, 2026 |
Schwab Charles R.
|
Chair |
Sell |
57.5
|
+23,555
|
0.02%
|
✗
|
$1.5M |
| Mar 1, 2026 |
Mar 3, 2026 |
Bettinger Walter W
|
Chair |
Sell |
100.0
|
+81,014
|
14.99%
|
✗
|
$5.8M |
| Mar 1, 2026 |
Mar 3, 2026 |
Wurster Richard A
|
CEO |
Sell |
100.0
|
+39,261
|
24.31%
|
✗
|
$2.2M |
| Mar 1, 2026 |
Mar 3, 2026 |
Morgan Peter J. III
|
General Counsel |
Sell |
97.5
|
+6,952
|
992.67%
|
✗
|
$410.9K |
| Feb 27, 2026 |
Mar 3, 2026 |
Beatty Jonathan S
|
MD, Head of Advisor Services |
Sell |
22.5
|
-2,030
|
-3.67%
|
✗
|
$193.5K |
| Feb 26, 2026 |
Mar 3, 2026 |
Ellis Stephen A
|
Director |
Sell |
17.5
|
-10,725
|
-10.91%
|
✗
|
$1M |
| Feb 25, 2026 |
Feb 27, 2026 |
Howard Dennis
|
MD, Chief Tech, OPS & Data Off |
Sell |
8.8
|
-27,903
|
-72.72%
|
✓
|
$2.7M |
| Feb 9, 2026 |
Feb 11, 2026 |
Schwab Charles R.
|
Chair |
Sell |
32.5
|
-218,613
|
-0.23%
|
✗
|
$16.9M |
| Feb 6, 2026 |
Feb 10, 2026 |
Bettinger Walter W
|
Chair |
Sell |
16.3
|
-67,514
|
-11.06%
|
✗
|
$7M |
| Feb 6, 2026 |
Feb 10, 2026 |
DODDS CHRISTOPHER V
|
Director |
Sell |
17.5
|
-11,825
|
-2.54%
|
✗
|
$1.2M |
|
Feb 9, 2026 |
Howard Dennis
|
MD, Chief Tech, OPS & Data Off |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2026 |
Feb 5, 2026 |
Schwab Charles R.
|
Chair |
Sell |
40.0
|
-164,600
|
-0.17%
|
✗
|
$17.1M |
| Feb 3, 2026 |
Feb 5, 2026 |
Bettinger Walter W
|
Chair |
Sell |
15.0
|
-257,410
|
-13.69%
|
✗
|
$26.8M |
| Feb 2, 2026 |
Feb 3, 2026 |
Morgan Peter J. III
|
General Counsel |
Sell |
20.0
|
-7,595
|
-91.56%
|
✗
|
$792.8K |
| Jan 29, 2026 |
Feb 2, 2026 |
Schwab Charles R.
|
Chair |
Sell |
40.0
|
-145,650
|
-0.15%
|
✗
|
$15M |
| Jan 26, 2026 |
Jan 28, 2026 |
Schwab Charles R.
|
Chair |
Sell |
40.0
|
-206,332
|
-0.10%
|
✗
|
$21.3M |
| Jan 22, 2026 |
Jan 26, 2026 |
Schwab-Pomerantz Carolyn
|
Director |
Sell |
17.5
|
-42,865
|
-2.27%
|
✗
|
$4.5M |
| Jan 22, 2026 |
Jan 23, 2026 |
Beatty Jonathan S
|
MD, Head of Advisor Services |
Sell |
30.0
|
-2,000
|
-8.41%
|
✓
|
$210K |
| Jan 2, 2026 |
Jan 6, 2026 |
Brown Marianne Catherine
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
HERRINGER FRANK C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Ellis Stephen A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Ruffel Charles A.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2025 |
Dec 29, 2025 |
Beatty Jonathan S
|
MD, Head of Advisor Services |
Sell |
26.3
|
-2,000
|
-14.36%
|
✓
|
$204K |
| Dec 16, 2025 |
Dec 18, 2025 |
Ellis Stephen A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 19, 2025 |
Nov 20, 2025 |
Ruffel Charles A.
|
Director |
Neutral |
27.5
|
-8,372
|
-26.74%
|
✗
|
- |
| Nov 12, 2025 |
Nov 14, 2025 |
Murtagh Nigel J
|
Chief Risk Officer |
Neutral |
27.5
|
-1,032
|
-1.68%
|
✗
|
- |
| Nov 12, 2025 |
Nov 14, 2025 |
Beatty Jonathan S
|
MD, Head of Advisor Services |
Sell |
12.5
|
-3,072
|
-20.49%
|
✓
|
$301.1K |
| Nov 13, 2025 |
Nov 14, 2025 |
SNEED PAULA A
|
Director |
Neutral |
27.5
|
-8,680
|
-7.63%
|
✗
|
- |
| Nov 12, 2025 |
Nov 14, 2025 |
Schwab Charles R.
|
Chair |
Neutral |
52.5
|
-52,500
|
-0.05%
|
✗
|
- |
| Nov 10, 2025 |
Nov 13, 2025 |
Schwab-Pomerantz Carolyn
|
Director |
Neutral |
52.5
|
-298
|
-0.02%
|
✗
|
- |
| Nov 10, 2025 |
Nov 13, 2025 |
Bettinger Walter W
|
Chair |
Neutral |
27.5
|
-61,388
|
-10.16%
|
✗
|
- |
| Nov 10, 2025 |
Nov 12, 2025 |
Woolway Paul V
|
MD, Chief Banking Officer |
Neutral |
45.0
|
-293
|
-0.44%
|
✗
|
- |
| Nov 7, 2025 |
Nov 10, 2025 |
Craig Jonathan M.
|
MD, Head of Investor Services |
Sell |
17.5
|
-35,188
|
-100.00%
|
✗
|
$3.4M |
| Oct 28, 2025 |
Oct 30, 2025 |
Schwab Charles R.
|
Chair |
Sell |
40.0
|
-109,150
|
-0.11%
|
✗
|
$10.3M |
| Oct 29, 2025 |
Oct 30, 2025 |
Woolway Paul V
|
MD, Chief Banking Officer |
Neutral |
27.5
|
-3,822
|
-5.49%
|
✗
|
- |
| Oct 23, 2025 |
Oct 24, 2025 |
Schwab Charles R.
|
Chair |
Neutral |
52.5
|
-50,345
|
-0.05%
|
✗
|
- |
| Oct 1, 2025 |
Oct 3, 2025 |
Brown Marianne Catherine
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 1, 2025 |
Oct 3, 2025 |
Ellis Stephen A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 1, 2025 |
Oct 3, 2025 |
Ruffel Charles A.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 1, 2025 |
Oct 3, 2025 |
HERRINGER FRANK C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 2, 2025 |
Oct 3, 2025 |
Schwab-Pomerantz Carolyn
|
Director |
Sell |
40.0
|
-24,000
|
-1.26%
|
✓
|
$2.2M |
| Oct 1, 2025 |
Oct 2, 2025 |
Woolway Paul V
|
MD, Chief Banking Officer |
Sell |
35.0
|
-3,205
|
-4.40%
|
✓
|
$299.1K |